The next driver of which I am aware is the Data from a recently completed Phase 2 Trial with 68 participants( 14 Alzheimers and 54 Parkinsons) . They have said that data should be available this quarter and with the Biogen Clock of 90 Days ticking , I imagine all kitchen sinks will be thrown into the market by ANVS, SAVA and AVXL during this time frame. If they miss this window to stop Biogen it will be a true human tragedy (IMO)